Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE).

Clinical nephrology·2008
Same author

Donor-derived human herpes virus 8-related Kaposi's sarcoma in renal allograft ureter.

Transplant infectious disease : an official journal of the Transplantation Society·2007
Same author

Successful therapeutic use of rituximab in refractory Wegener's granulomatosis after renal transplantation.

Clinical nephrology·2007
Same author

Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.

Alimentary pharmacology & therapeutics·2007
Same author

Antiviral treatment after solid organ transplantation.

Lancet (London, England)·2005

Related Experiment Video

Updated: Jul 5, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

Hepatorenal syndrome.

P Sweny1

  • 1Department of Nephrology and Transplantation, Trie Royal Free Hospital, London, United Kingdom.

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
|July 1, 1996
PubMed
Summary

Hepatorenal syndrome (HRS), a kidney complication in advanced liver disease, can be managed by avoiding nephrotoxic agents. Early intervention and treatments like shunting offer hope, while liver transplantation provides a cure.

Area of Science:

  • Nephrology
  • Hepatology
  • Internal Medicine

Background:

  • Hepatorenal syndrome (HRS) is a frequent complication in patients with advanced liver disease.
  • This condition represents a functional renal failure, posing significant risks to affected individuals.
  • Effective management strategies are crucial to mitigate the development of HRS.

Purpose of the Study:

  • To outline the pathogenesis and management of hepatorenal syndrome.
  • To highlight the importance of avoiding nephrotoxic agents in patients at risk.
  • To discuss current and potential therapeutic interventions for HRS.

Main Methods:

  • Review of existing literature on hepatorenal syndrome.
  • Analysis of the pathophysiological mechanisms involved in HRS.

Related Experiment Videos

Last Updated: Jul 5, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
16:19

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure

Published on: September 13, 2014

  • Evaluation of current medical and interventional treatment options.

    • Main Results:

    • Potentially nephrotoxic agents, including certain drugs and x-ray contrast media, should be avoided.
    • Pathogenesis likely involves sympathetic overactivity, endotoxin, nitric oxide, endothelin, and altered arachidonic acid metabolism.
    • Abnormalities in HRS are often linked to inadequate effective arterial blood volume and compensatory mechanisms.

    Conclusions:

    • Medical management of HRS has shown limited success.
    • Trans-cutaneous intra-hepatic portal systemic shunting presents a potential therapeutic option.
    • Orthotopic liver transplantation is the definitive curative treatment for hepatorenal syndrome.